97 results
8-K
EX-99.1
COR
Cencora Inc.
1 May 24
Cencora Reports Fiscal 2024 Second Quarter Results
6:33am
to the same period in the previous fiscal year, primarily due to higher litigation and opioid-related expenses and an increase in distribution, selling … million, a 1.3 percent decrease compared to the same period in the previous fiscal year as the increases in litigation and opioid-related expenses
424B2
COR
Cencora Inc.
7 Feb 24
Prospectus for primary offering
12:00am
controlled substances, including due to failure to achieve a global resolution of the multi-district opioid litigation and other related state court
424B5
COR
Cencora Inc.
5 Feb 24
Prospectus supplement for primary offering
9:43am
to achieve a global resolution of the multi-district opioid litigation and other related state court litigation, and any related disputes, including
8-K
EX-99.1
2jywv7tp5qb9 w5
31 Jan 24
Cencora Reports Fiscal 2024 First Quarter Results
6:37am
8-K
EX-99.1
yt13b8li8gw89y1t
2 Nov 23
Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
6:35am
424B7
iakpknrvd2x8vh
7 Aug 23
Prospectus with selling stockholder info
5:07pm
424B7
fq3k5vop 9jhghag9
3 Aug 23
Prospectus with selling stockholder info
5:28pm
8-K
EX-99.1
l4aeh40iq4q5km24vqcg
2 Aug 23
Fiscal 2023 Third Quarter Results
6:34am
8-K
EX-99.1
ksoqx r56ji1e
2 May 23
Fiscal 2023 Second Quarter Results
6:35am
424B7
gypudh
8 Nov 22
Prospectus with selling stockholder info
5:25pm
424B7
6t3v2v f8
7 Nov 22
Prospectus with selling stockholder info
5:27pm
8-K
EX-99.1
wy80ti4qg2yyp8tqum
7 Nov 22
Other Events
5:10pm